Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy.
Oncol Lett
; 24(1): 224, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35720472
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncol Lett
Year:
2022
Type:
Article